Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beacon Medical Australia is an Australian medical cannabis company and a wholly owned subsidiary of MediPharm Labs focused on supplying pharmaceutical-grade cannabinoid medicines to patients and healthcare professionals in Australia. The company markets and distributes medicinal cannabis products across multiple formats, including flower, full-spectrum oils, CBD isolate oil, balanced oil, THC-dominant oil, and inhalation cartridges. Beacon Medical positions itself as an education- and access-focused supplier, supporting doctors, pharmacists, and patients with information on prescribing, dispensing, and navigating Australian regulatory pathways. Its products are backed by GMP manufacturing and extraction capabilities from its parent company, and the brand has established a commercial presence in the Australian medicinal cannabis market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beacon Medical Australia.